knowledge -WSS

knowledge

author：comprehensive 2025-09-28 01:36:23 - browse：2677

Sen. Rand Paul (C) (R-KY) questions Homeland Security Secretary Alejandro Mayorkas and FBI Director Christopher Wray during a hearing held by the Senate Homeland Security and Governmental Affairs Committee October 31, 2023 in Washington, DC. — Sen. Rand Paul (R-Ky.) Win McNamee/Getty Images

WASHINGTON — A Senate panel Wednesday passed a bill aimed at preventing certain Chinese companies from doing business in the United States. The sole no vote was by Sen. Rand Paul (R-Ky.), who worries that Congress is using anger toward China as a cover for advancing parochial interests.

Many in Congress are worried the Chinese government and military are using the rising dominance of national companies to gather Americans’ genetic information, which could be used for reasons that range from creating bioweapons to giving China a leg up in drug development.

The Biosecure Act, by Homeland Security and Governmental Affairs Chair Gary Peters (D-Mich.), is a response to those concerns. The bill would block the U.S. government from contracting with companies that do business with Chinese “biotechnology companies of concern,” and it names four companies that must be on that list: BGI Genomics, MGI, Complete Genomics, WuXi AppTec, and any subsidiary, parent affiliate, or successor of these companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： CEOs share strategies for surviving biotech slump

hotspot

WSS

ReNAgade cuts staff seven months after raising $300 million

UnitedHealth’s board chair also owns a personal investment firm

Diagnostic tests are hitting their mathematical limits

Senate committee scrutinizes Medicare Advantage brokers

Solve the antibiotic resistance crisis with preventive drugs

The explosion of genetic testing requires a new approach

explore

knowledge

entertainment

Guidelines to prevent youth baseball injuries need more muscle

First Opinion Podcast: Long Covid needs a new approach

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Beam Therapeutics to lay off 20% of its staff, re

BioMarin wins approval for gene therapy to treat hemophilia A

Solve the antibiotic resistance crisis with preventive drugs

In Memoriam: Notable people who died in 2023

CEOs share strategies for surviving biotech slump

New air purifier tech could be key to improving indoor air quality

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

hotspot

Rep. Raul Ruiz on the physician shortage and more

NIH confirmation hearing shows politicization of research

Eli Lilly expects to double planned employment in Boston center

The EU Joint Clinical Assessment needs to live up to its promise

Senate committee scrutinizes Medicare Advantage brokers

NIH confirmation hearing shows politicization of research

hotspot

focus

hotspot

entertainment